Yin-Hu Wang, Wenyi Li, Maxwell McDermott, Ga-Yeon Son, George Maiti, Fang Zhou, Anthony Y. Tao, Dimitrius Raphael, Andre L. Moreira, Boheng Shen, Martin Vaeth, Bettina Nadorp, Shukti Chakravarti, Rodrigo S. Lacruz, Stefan Feske
{"title":"IFN-γ–producing T H 1 cells and dysfunctional regulatory T cells contribute to the pathogenesis of Sjögren’s disease","authors":"Yin-Hu Wang, Wenyi Li, Maxwell McDermott, Ga-Yeon Son, George Maiti, Fang Zhou, Anthony Y. Tao, Dimitrius Raphael, Andre L. Moreira, Boheng Shen, Martin Vaeth, Bettina Nadorp, Shukti Chakravarti, Rodrigo S. Lacruz, Stefan Feske","doi":"10.1126/scitranslmed.ado4856","DOIUrl":null,"url":null,"abstract":"Sjögren’s disease (SjD) is an autoimmune disorder characterized by progressive salivary and lacrimal gland dysfunction, inflammation, and destruction, as well as extraglandular manifestations. SjD is associated with autoreactive B and T cells, but its pathophysiology remains incompletely understood. Abnormalities in regulatory T (T <jats:sub>reg</jats:sub> ) cells occur in several autoimmune diseases, but their role in SjD is ambiguous. We had previously shown that the function and development of T <jats:sub>reg</jats:sub> cells depend on store-operated Ca <jats:sup>2+</jats:sup> entry (SOCE), which is mediated by ORAI1 Ca <jats:sup>2+</jats:sup> channels and stromal interaction protein 1 (STIM1) and STIM2. Here, we show that mice with a Foxp3 <jats:sup>+</jats:sup> T <jats:sub>reg</jats:sub> cell–specific deletion of <jats:italic>Stim1</jats:italic> and <jats:italic>Stim2</jats:italic> develop a phenotype that fulfills all classification criteria of human SjD. Mutant mice have salivary and lacrimal gland inflammation characterized by strong lymphocyte infiltration and transcriptional signatures dominated by T helper 1 (T <jats:sub>H</jats:sub> 1) and interferon (IFN) signaling. CD4 <jats:sup>+</jats:sup> T cells from mutant mice are sufficient to induce SjD-like disease in an IFN-γ–dependent manner. Inhibition of IFN signaling with the JAK1/2 inhibitor baricitinib alleviated CD4 <jats:sup>+</jats:sup> T cell–induced SjD in mice. These findings are consistent with the transcriptional profiles of CD4 <jats:sup>+</jats:sup> T cells from patients with SjD, which indicate enhanced T <jats:sub>H</jats:sub> 1 but reduced memory T <jats:sub>reg</jats:sub> cell function. Together, our study provides evidence for a critical role of dysfunctional T <jats:sub>reg</jats:sub> cells and IFN-γ–producing T <jats:sub>H</jats:sub> 1 cells in the pathogenesis of SjD.","PeriodicalId":21580,"journal":{"name":"Science Translational Medicine","volume":"86 1","pages":""},"PeriodicalIF":15.8000,"publicationDate":"2024-12-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Science Translational Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1126/scitranslmed.ado4856","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CELL BIOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Sjögren’s disease (SjD) is an autoimmune disorder characterized by progressive salivary and lacrimal gland dysfunction, inflammation, and destruction, as well as extraglandular manifestations. SjD is associated with autoreactive B and T cells, but its pathophysiology remains incompletely understood. Abnormalities in regulatory T (T reg ) cells occur in several autoimmune diseases, but their role in SjD is ambiguous. We had previously shown that the function and development of T reg cells depend on store-operated Ca 2+ entry (SOCE), which is mediated by ORAI1 Ca 2+ channels and stromal interaction protein 1 (STIM1) and STIM2. Here, we show that mice with a Foxp3 + T reg cell–specific deletion of Stim1 and Stim2 develop a phenotype that fulfills all classification criteria of human SjD. Mutant mice have salivary and lacrimal gland inflammation characterized by strong lymphocyte infiltration and transcriptional signatures dominated by T helper 1 (T H 1) and interferon (IFN) signaling. CD4 + T cells from mutant mice are sufficient to induce SjD-like disease in an IFN-γ–dependent manner. Inhibition of IFN signaling with the JAK1/2 inhibitor baricitinib alleviated CD4 + T cell–induced SjD in mice. These findings are consistent with the transcriptional profiles of CD4 + T cells from patients with SjD, which indicate enhanced T H 1 but reduced memory T reg cell function. Together, our study provides evidence for a critical role of dysfunctional T reg cells and IFN-γ–producing T H 1 cells in the pathogenesis of SjD.
期刊介绍:
Science Translational Medicine is an online journal that focuses on publishing research at the intersection of science, engineering, and medicine. The goal of the journal is to promote human health by providing a platform for researchers from various disciplines to communicate their latest advancements in biomedical, translational, and clinical research.
The journal aims to address the slow translation of scientific knowledge into effective treatments and health measures. It publishes articles that fill the knowledge gaps between preclinical research and medical applications, with a focus on accelerating the translation of knowledge into new ways of preventing, diagnosing, and treating human diseases.
The scope of Science Translational Medicine includes various areas such as cardiovascular disease, immunology/vaccines, metabolism/diabetes/obesity, neuroscience/neurology/psychiatry, cancer, infectious diseases, policy, behavior, bioengineering, chemical genomics/drug discovery, imaging, applied physical sciences, medical nanotechnology, drug delivery, biomarkers, gene therapy/regenerative medicine, toxicology and pharmacokinetics, data mining, cell culture, animal and human studies, medical informatics, and other interdisciplinary approaches to medicine.
The target audience of the journal includes researchers and management in academia, government, and the biotechnology and pharmaceutical industries. It is also relevant to physician scientists, regulators, policy makers, investors, business developers, and funding agencies.